Skip to main content
Log in

Serum pepsinogens as markers of response to therapy forHelicobacter pylori gastritis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We have investigated the effect of therapy forHelicobacter pylori gastritis on serum concentrations of pepsinogen I and II in 43 patients. In the 22 patients in whom therapy resulted in dramatic decrease in gastritis scores and in clearance of the bacteria, there was a highly significant (P=0.0001) fall in mean serum pepsinogen II from 13.3±0.8 to 7.9±0.7 μg/liter, and a less pronounced fall in pepsinogen I from 89.0±5.9 to 78.5±0.4 μg/liter (P=0.01). These changes resulted in a significant (P=0.01) increase in the pepsinogen I/II ratio. In contrast, nonsignificant declines of 3.5% and 11.6% were observed in mean pepsinogen I and II levels in the 21 patients whose gastritis failed to resolve histologically and whose infection did not clear. These findings suggest that serum pepsinogen levels, especially pepsinogen II, are a new tool that may be found to be clinically useful in evaluation of treatment outcome in patients withH. pylori-associated gastritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Samloff IM, Varis K, Ihamaki T: Determination of gastric mucosal histology by serological and secretory tests. Gastroenterology 80:1269, 1981

    Google Scholar 

  2. Marshall BJ:Campylobacter pyloridis and gastritis. J Infect Dis 153:650–655, 1986

    Google Scholar 

  3. Ruiz B, Janney A, Diavolitsis S, Correa P: One minute test forCampylobacter pylori. Am J Gastroenterol 84:202, 1989

    Google Scholar 

  4. Garvey W, Fathi RT, Bigelow F: Modified Steiner for the demonstration of spirochetes. J Histotechnol 8:15–17, 1985

    Google Scholar 

  5. Correa P: Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 83:504–509, 1988

    Google Scholar 

  6. Samloff IM: Pepsinogens I and II, purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 82:26–33, 1982

    Google Scholar 

  7. Spiro HM, Schwartz RD: A cause of temporary achlorhydria and hyperpepsinemia. N Engl J Med 259:682–684, 1958

    Google Scholar 

  8. Samloff IM, Townes PI: Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum and gastric mucosa. Gastroenterology 58:462, 1970

    Google Scholar 

  9. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 83:204–209, 1982

    Google Scholar 

  10. Samloff IM: Slow moving protease and the seven pepsinogens: Electrophoretic demonstration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology 47:659, 1969

    Google Scholar 

  11. Oderda G, Vaira D, Holton J, Ainley C, Altare F, Boero M, Smith A, Ansaldi N:Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 36:572–576, 1991

    Google Scholar 

  12. Oderda G, Vaira D, Dell'Olio D, Holton J, Forni M, Altare F, Ansaldi N: Serum pepsinogen I and gastrin concentrations in children positive forHelicobacter pylori. J Clin Pathol 43:762–765, 1990

    Google Scholar 

  13. Cave TR, Cave DR:Helicobacter pylori stimulating pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol 26(suppl 181):9–14, 1991

    Google Scholar 

  14. Di Napoli A, Boero M, Petrino R, Bellis D, Brossa PC, Chiandussi L: Histological and biochemical modifications afterHelicobacter pylori eradication. Gastroenterology 100:A55, 1991

    Google Scholar 

  15. Truesdale RA, Chamberlain CE, Martin DF, Maydonvvitch CL, Peña S: Serology predicts treatment eradication ofHelicobacter pylori. Gastroenterology 100:A176, 1991

    Google Scholar 

  16. Fraser AG, Prewett EJ, Pounder RE, Samloff IM: Twentyfour hour hyperpepsinogenaemia inHelicobacter pylori-positive subjects is abolished by eradication of the infection. Gastroenterology 102:A70, 1992

    Google Scholar 

  17. Hengels KJ, Jablonowski H, Porschen R, Strohmeyer G: Serum pepsinogen in patients with gastritis and duodenal ulcer disease. Gastroenterology 102:A81, 1992

    Google Scholar 

  18. Plebani M, Delle Fave GF, Annibale B, Stanghellini V, Gasperoni S, Corinaldesi R, DiMario F: Pepsinogens A and C are related toHelicobacter pylori infection. Gastroenterology 102:A148, 1992

    Google Scholar 

  19. Vaira D, Holton J, Cairns SR, Falgon M, Polydorou A, Dowsett JF, Salmon PR: Antibody titres toCampylobacter pylori after treatment for gastritis. BMJ 297:397, 1988

    Google Scholar 

  20. Cutler A, Schubert A, Schubert T:H. pylori serology predicts treatment success. Gastroenterology 102:A53, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by NIH grants P01-CA-28842 and R01-AI-25590.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, F.M., Correa, P., Fontham, E. et al. Serum pepsinogens as markers of response to therapy forHelicobacter pylori gastritis. Digest Dis Sci 38, 2081–2086 (1993). https://doi.org/10.1007/BF01297088

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01297088

Key Words

Navigation